CLINICAL PROTOCOL AND DATA MANAGEMENT (CPDM) Part I: Clinical Research Support (CRS). CRS includes 65 FTEs who provide centralized support for the conduct of cancer-related clinical research on behalf of the all Consortium institutions. The integrated CRS provides the infrastructure and processes to efficiently and effectively support over 176 Consortium investigators on all cancer clinical research studies and serves as the central repository of clinical research information. In FY 2018, CRS reported the recruitment of 10,716 individuals onto all clinical research studies (5,424 interventional and 5,292 non-interventional accruals) and facilitated activation of 180 studies (150 interventional), including 66 institutional and externally peer-reviewed studies. Part II: Data and Safety Monitoring (DSM). DSM is required for all interventional studies. For investigator-initiated studies, a well-established internal Data and Safety Monitoring Committee (DSMC) performs risk-based monitoring to ensure the highest levels of patient safety. In addition, effective quality control functions promote protocol compliance in accordance with sponsor requirements and the NCI- approved Consortium Data Safety Monitoring Plan (DSMP). In FY 2018, the DSMC monitored 118 studies, which included the review of 58 reports from study-specific DSMBs. Part III: Inclusion of Women and Minorities in Research. The Consortium leads multiple, proactive efforts to promote the recruitment of women and minorities. In FY 2018, among the 5,424 individuals enrolled onto interventional studies, 61% were women and enrollments consisted of 10% ethnic Hispanics and 23% non-White racial minorities, which compares favorably to catchment area demographics of 50% women, 10% Hispanic, and 24% non-White racial minorities. Part IV: Inclusion of Children in Research. The Consortium supports the NIH policy on the inclusion of children in research. The Consortium is an active member of the National Clinical Trials Network (NCTN) Children?s Oncology Group and several other national pediatric oncology trial consortia. Enhancements to our Children?s clinical research infrastructure have supported significant growth in Consortium enrollments. In FY 2018, 153 of the 286 (54%) newly registered pediatric patients enrolled on an interventional treatment trial compared to 85 of 240 (35%) in FY 2014. An additional 296 children were accrued to interventional non-treatment trials in FY 2018, up from 195 in FY 2014.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA015704-45
Application #
9853670
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Hempstead, Bridgette; Green, Cynthia; Briant, Katherine J et al. (2018) Community Empowerment Partners (CEPs): A Breast Health Education Program for African-American Women. J Community Health 43:833-841
OhAinle, Molly; Helms, Louisa; Vermeire, Jolien et al. (2018) A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV. Elife 7:
Syrjala, Karen L; Yi, Jean C; Artherholt, Samantha B et al. (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv 12:560-570
Liu, Yang; He, Qianchan; Sun, Wei (2018) Association analysis using somatic mutations. PLoS Genet 14:e1007746
Glaser, Adam K; Chen, Ye; Yin, Chengbo et al. (2018) Multidirectional digital scanned light-sheet microscopy enables uniform fluorescence excitation and contrast-enhanced imaging. Sci Rep 8:13878
Liu, Yanyan; Xiong, Sican; Sun, Wei et al. (2018) Joint Analysis of Strain and Parent-of-Origin Effects for Recombinant Inbred Intercrosses Generated from Multiparent Populations with the Collaborative Cross as an Example. G3 (Bethesda) 8:599-605
Mora-Pinzon, Maria C; Trentham-Dietz, Amy; Gangnon, Ronald E et al. (2018) Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk. Nutr Cancer 70:441-446
Shirts, Brian H; Konnick, Eric Q; Upham, Sarah et al. (2018) Using Somatic Mutations from Tumors to Classify Variants in Mismatch Repair Genes. Am J Hum Genet 103:19-29
Du, Jing; Flynn, Ryan; Paz, Katelyn et al. (2018) Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. Blood 131:1743-1754
Suzuki, Aussie; Gupta, Amitabha; Long, Sarah K et al. (2018) A Kinesin-5, Cin8, Recruits Protein Phosphatase 1 to Kinetochores and Regulates Chromosome Segregation. Curr Biol 28:2697-2704.e3

Showing the most recent 10 out of 1267 publications